NGMBIO

Serial Number 97124968
733

Registration Progress

Application Filed
Nov 15, 2021
Under Examination
Jul 4, 2023
Approved for Publication
May 9, 2023
Published for Opposition
May 9, 2023
Registered

Attorney Assistance

Statement of Use Due - Extension 4 Granted
Due: Jan 04, 2026 154 days

Trademark Image

NGMBIO

Basic Information

Serial Number
97124968
Filing Date
November 15, 2021
Published for Opposition
May 9, 2023
Drawing Code
5

Status Summary

Current Status
Active
Status Code
733
Status Date
May 12, 2025
Application
Pending
Classes
005 042 044

Rights Holder

NGM Biopharmaceuticals, Inc.

03
Address
333 Oyster Point Boulevard
South San Francisco, CA 94080

Ownership History

NGM Biopharmaceuticals, Inc.

Original Applicant
03
South San Francisco, CA

NGM Biopharmaceuticals, Inc.

Owner at Publication
03
South San Francisco, CA

Legal Representation

Attorney
Ilene B. Tannen

USPTO Deadlines

Next Deadline
154 days remaining
Statement of Use Due - Extension 4 Granted
Due Date
January 04, 2026
Extension Available
Until July 04, 2024

Application History

41 events
Date Code Type Description Documents
Jun 23, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jun 23, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jun 23, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
May 13, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 12, 2025 EX4G S SOU EXTENSION 4 GRANTED Loading...
May 12, 2025 EXT4 S SOU EXTENSION 4 FILED Loading...
May 12, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 18, 2024 EX3G S SOU EXTENSION 3 GRANTED Loading...
Nov 18, 2024 EXT3 S SOU EXTENSION 3 FILED Loading...
Nov 18, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 18, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 24, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 23, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
May 23, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 23, 2024 EX2G S SOU EXTENSION 2 GRANTED Loading...
Nov 21, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 17, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 17, 2023 EX1G S SOU EXTENSION 1 GRANTED Loading...
Nov 17, 2023 EXT1 S SOU EXTENSION 1 FILED Loading...
Jul 4, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 9, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 9, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 19, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 31, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 18, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Mar 18, 2023 ALIE A ASSIGNED TO LIE Loading...
Mar 17, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Mar 17, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Mar 17, 2023 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Mar 1, 2023 GNRT O NON-FINAL ACTION E-MAILED Loading...
Mar 1, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Mar 1, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Feb 2, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 1, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 1, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 8, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 8, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Aug 8, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 4, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 19, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 18, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the prevention and treatment of cancer, retinal, liver, metabolic, autoimmune, cardiovascular, neurological, immune, musculoskeletal, endocrine and hematological diseases and disorders
Class 042
Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Class 044
Providing medical information relating to cancer, retinal diseases and liver and metabolic diseases

Additional Information

Design Mark
The mark consists of the combined words "ngmBIO" with "ngm" in lowercase stylized letters and "BIO" in uppercase stylized letters.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005 042 044

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIO"